Colorectal cancer (CRC), known as bowel cancer and colon cancer, is the progress of cancer from the colon or rectum (
1). The incidence of CRC is increasing globally, and the greatest increase is in low- to middle-income countries (
2). However, old age and factors associated with lifestyle are responsible in most patients with CRC, but genetic disorders could also be mentioned as another reason for CRC (
3). Diet, obesity, and lack of physical activity were mentioned as risk factors. In regards to gender, it affects both male and females equally (
4). In fact, CRC was mentioned as a disease of developed countries (accounts for over 63%) with a western culture (
5). With a gradual improvement in 5-year survival rate, national statistics have reported reductions in the incidence and death rates (
6). The highest CRC incidence rates were reported for North America, Europe, and Australia. There are reports regarding an increase in incidence for Japan, Thailand, and Iran. In regards to Saudia Arabia, the double rate was reported since 1994 (
7-
9). There is an attribution of half of the incidence associated with mortality due to CRC globally. Survival is extremely reliant upon the stage of disease at finding, and characteristically sorts from a 5-year survival rate at the localized stage; 70% for local and 10% for individuals identified for metastatic cancer. Around 20% of those with development in CRC have a background with a positive family history (
10-
13).